Phase 2 trial of daily, oral epigallocatechin gallate in patients with light-chain amyloidosis
Crossref DOI link: https://doi.org/10.1007/s12185-016-2112-1
Published Online: 2016-11-04
Published Print: 2017-03
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Meshitsuka, Sohsuke
Shingaki, Sumito
Hotta, Masatoshi
Goto, Miku
Kobayashi, Makoto
Ukawa, Yuuichi
Sagesaka, Yuko M.
Wada, Yasuyo
Nojima, Masanori
Suzuki, Kenshi
License valid from 2016-11-04